AYTU BIOPHARMA, INC Accretion of Discount (Deprecated 2016-01-31)
AYTU BIOPHARMA, INC (AYTU) reported Accretion of Discount (Deprecated 2016-01-31) of $173.00 thousand for the 9-month period ending 2016-03-31, per its 10-Q filed 2016-05-11.
Discontinued › Notes
us-gaap:AccretionOfDiscount · last filed 2016-05-11
- AYTU BIOPHARMA, INC accretion of discount (deprecated 2016-01-31) for the quarter ending 2016-03-31 was $0.00.
- AYTU BIOPHARMA, INC accretion of discount (deprecated 2016-01-31) for the quarter ending 2015-03-31 was $0.00.
| Period end | Accretion of Discount (Deprecated 2016-01-31) 3 month | Accretion of Discount (Deprecated 2016-01-31) 6 month | Accretion of Discount (Deprecated 2016-01-31) 9 month |
|---|---|---|---|
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $173.00K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $173.00K 10-Q · filed 2016-02-11 | ||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $173.00K 10-Q · filed 2016-05-11 | |
| 2014-12-31 | $173.00K 10-Q · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |